No Data
No Data
Galapagos CEO Paul Stoffels to Retire; Henry Gosebruch Named SpinCo Chief
Needham Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $5
BofA Securities Initiates Neumora Therapeutics(NMRA.US) With Sell Rating, Announces Target Price $1
Express News | Neumora Therapeutics Inc : BofA Global Research Cuts to Underperform From Buy; Cuts Price Objective to $1 From $7
Guggenheim Downgrades Neumora Therapeutics to Neutral
William Blair Downgrades Neumora Therapeutics(NMRA.US) to Hold Rating